Apricus Biosciences Inc news

   Watch this stock
Showing stories 1 - 10 of about 44   

Articles published

APRI 1.62 +0.05 (3.18%)
price chart
Apricus Biosciences Director Sandford D. Smith Buys 26500 Shares (APRI)
Apricus Biosciences Inc logo Apricus Biosciences (NASDAQ:APRI) Director Sandford D. Smith acquired 26,500 shares of the company's stock in a transaction dated Thursday, October 23rd.
Related articles »  
Apricus Biosciences = Superball (APRI)
Be careful if you think you know the real reason Apricus Biosciences Inc. (NASDAQ:APRI) turned around last week and started heading higher.
Forendo Pharma announces the US licensing of fispemifene to Apricus ...
Forendo Pharma Oy, a Karolinska Development AB portfolio company, announced today that it has entered into a definitive agreement to out-license the US development and commercialization rights for fispemifene to Apricus Biosciences Inc. Forendo is ...
Watch List Highlights - Apricus Biosciences Inc (NASDAQ:APRI), Neptune ...  Street Newswire (registration)
Apricus Expands Development Pipeline With the In-Licensing of U.S. Rights ...  CNNMoney
Related articles »  
Investor's Alert: Cliffs Natural Resources Inc (NYSE:CLF), Apricus Biosciences ...
Cliffs Natural Resources Inc (NYSE:CLF), a mining and natural-resources company, received an investment-rating downgrade Monday from analysts at JPMorgan to a neutral rating from overweight.
Apricus Biosciences Announces Notice of Allowance of U.S. Patent Application ...
Apricus Biosciences, Inc. APRI, +1.95% a biopharmaceutical company advancing innovative medicines to meet the needs of patients, today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S.
Apricus Bioscience Inc.: Apricus Biosciences Announces Notice of Allowance ...  The Wall Street Transcript
Related articles »  
Apricus Biosciences, Inc. (APRI) � Developing Novel Health Solutions
October 3, 2014 (Investorideas.com Newswire) San Diego-based Apricus Biosciences is finding solutions for unmet medical needs.
Apricus Biosciences to Present at the 13th Annual BIO Investor Forum
Apricus Biosciences, Inc. APRI, -4.88% a biopharmaceutical company advancing innovative medicines to meet the needs of patients, today announced that Richard Pascoe, Chief Executive Officer, will present at the 13th Annual BIO Investor Forum on ...
Related articles »  
Apricus Biosciences Inc (NASDAQ:APRI) Gets The USPTO Notice Of Allowance ...
Apricus Biosciences Inc (NASDAQ:APRI) said that it had got the Notice of Allowance of its Patent Application submitted to the USPTO.
Apricus Biosciences To Present At BIO Investor Forum; Webcast At 2:30 PM ET
(RTTNews.com) - Apricus Biosciences, Inc.( APRI ) will present at the 13th Annual BIO Investor Forum held at the Palace Hotel in San Francisco, CA.
Stocks To Watch: Comverse Inc (NASDAQ:CNSI), Apricus Biosciences Inc ...
Apricus Biosciences Inc (NASDAQ:APRI) disclosed on 13th October that the United States Patent and Trademark Office has issued the company a notice which provides allowance of its U.S.